Global
About Us
About Us
At a glance
Our journey through time
Making in India
Sanofi India Leadership Team
Chasing Miracles of Science
Chasing Miracles of Science
Protecting with vaccines
Solutions in Diabetes
Fighting rare diseases
Dare to Know Epilepsy
Transforming lives with transplantation
Change AD
Our Science
Our Science
Clinical Trials & Results
Clinical Trials & Results
Multiple Sclerosis
Pharmaceutical products
Vaccines
Specialty Care Products
For healthcare professionals
Social Impact
Social Impact
Access to health
Engaged communities
Environmental impact
Ethics & transparency
Consumer Healthcare
Consumer Healthcare
Health & well-being
Consumer Healthcare Leadership
Consumer Healthcare Products
Consumer Healthcare Products
All Products
Dulcoflex® - Constipation Relief Brand
For healthcare professionals
Investors
Investors
Our Business
Board of Directors and Leadership Team
Financial Results
Annual Reports
AGM
Investor Information
Disclosures Under Reg-46 of the Listing Regulations
CSR
Shareholder Corner
Media
Media
Media Release
Media
Media
Press Releases
Company statements
Investors
Investors
Board of Directors and Leadership Team
Board of Directors and Leadership Team
Board of Directors
Board Committees
Sanofi India Limited Leadership Team
Financial Results
Annual Reports
AGM
Scheme of Arrangement
Investor Information
Investor Information
Shareholding pattern
Corporate Governance
Analyst / Investor Meet
Postal Ballot
Secretarial Compliance Report
Related Party Disclosures
Annual Return
Stock Exchange Announcement and Disclosures
Newspaper Advertisement
Disclosures Under Reg. 46 of the Listing Regulations
Disclosures Under Reg. 46 of the Listing Regulations
Our Business
Letter of Appointment of Independent Directors
Composition of Board Committee
Code of Conduct and Policies
Familiarization Programme
Contact information for grievance redressal
Notice of Board Meeting
Financial results
Annual Reports
Shareholding Pattern
Analyst Meet
Notice given to shareholders by way advertisement
Audited Financial Results of Subsidiary
Secretarial Compliance Report
Policy for Determination of Materiality
KMP authorized for Determination of Materiality
Disclosures under Reg. 30 of the Listing Regulations
Annual Return
CSR
Shareholder’s Corner
Shareholder’s Corner
Unclaimed dividends
Unclaimed shares
Investor services
Contact Us
Careers
Careers
Hyderabad Hub
Contact Us
India
Investors
Disclosures Under Reg. 46 of the Listing Regulations
Disclosures under Reg. 30 of the Listing Regulations
Disclosures under Reg. 30 of the Listing Regulations
2024
Disclosures under Reg. 30 of the Listing Regulations 2024
Announcement under Regulation 30 (Nov 2024)
Change in Sr. Management (PDF • Nov 2024)
Announcement under Regulation 30 (PDF • June 2024)
Announcement under Regulation 30 (PDF • March 2024)
Announcement under Regulation 30 (PDF • Feb 2024)
Announcement under Regulation 30 (PDF • Jan 2024)
Change in Key Managerial Personnel (September 2024)
Announcement under Regulation 30 (PDF • Aug 2024)
Change in Sr. Management (PDF • June 2024)
Change in Directorate (PDF • May 2024)
Announcement under Regulation 30 (PDF • May 2024)
Announcement under Regulation 30 (PDF • March 2024 )
2023
Disclosures under Reg. 30 of the Listing Regulations 2023
Announcement under Regulation 30 (PDF )
Change in Sr. Management (PDF)
Announcement under Regulation 30 (PDF )
Reg 30 - Press Release by promoter Company (PDF )
Change in Directorate (PDF • September 2023 )
Change in Directorate (PDF • September 2023 )
Observation letters from BSE and NSE for the Scheme of Demerger (PDF • September 2023)
Change in Sr. Management (PDF • September 2023 )
Reg 30 – Pending Litigation (PDF • August 2023 )
Change in Sr. Management (PDF • August 2023 )
Resignation of Director (PDF • June 2023 )
Presentation of Investor/Analyst call May 2023 (PDF • May 2023 )
Reg 30 Scheme of arrangement (PDF • May 2023 )
Intimation for Investor / Analysts Call – May 2023 (PDF • May 2023 )
Announcement Under Regulation 30 - NLEM Communication (PDF • April 2023)
Investor / Analyst Meet Transcript 24.02.2023 (PDF • Feb 2023 )
Presentation for Investor / Analyst call – Feb 2023 (PDF • 2023-02-24 )
Intimation for Investor / Analysts Call (PDF • 2023-02-16)
Recording of Investor / Analyst Call - May 2023
Video • May 2023
2022
Disclosures under Reg. 30 of the Listing Regulations 2022
Announcement under Regulation 30 (LODR)-Change in Directorate (PDF • 2022-03-11 )
Reg 30 anouncement - NSE BSE NLEM (PDF • 2022-09-16)
Authorized officials for disclosure of Material information to Stock Exchange (PDF • 2022-06-01 )
Intimation for Investor Call (PDF • 2022-02-23 )
Resignation of Managing Director (PDF • 2022-01-13 )
2021
Disclosures under Reg. 30 of the Listing Regulations 2021
Divestment of Soframycin® and Sofradex® businesses (PDF • November 26, 2021 )
Resignation of Non-Executive Director (PDF • November 24, 2021 )
Appointment of Company Secretary and change in Compliance Officer (PDF • October 27, 2021 )
Resignation of Company Secretary (Key Managerial Personnel) & Change in Compliance Officer (PDF • August 13, 2021)
Slump Sale and transfer of the Nutraceuticals business of the Company (PDF • July 28, 2021 )
Investor Webinar Presentation (PDF • March 17, 2021 )
Intimation for Investor Webinar on 17th March 2021 (PDF • February 24, 2021 )
Appointment / Re-appointment of Directors, Re-appointment of Chairman (PDF • February 24, 2021 )
2020
Disclosures under Reg. 30 of the Listing Regulations 2020
Authorized officials for disclosure of material information to Stock Exchanges (PDF • October 06, 2020 )
Appointment of Chief Financial Officer (PDF • October 05, 2020 )
Resignation of Whole Time Director & Chief Financial Officer (PDF • September 16, 2020 )
Disclosure on Impact of COVID-19 (PDF • July 28, 2020 )
2019
Disclosures under Reg. 30 of the Listing Regulations 2019
Outcome of Board Meeting held on 10th September 2019 (PDF • September 11, 2019 )
Resignation of Whole Time Director (PDF • May 7, 2019 )
Clarification on the media report in ‘The Hindu’ (PDF • February 19, 2019)
2018
Disclosures under Reg. 30 of the Listing Regulations 2018
Clarification on the media report in the Indian Express (PDF • November 13, 2018)
Change in Chief Financial Officer (PDF • May 09, 2018)
2015
Disclosures under Reg. 30 of the Listing Regulations 2015
Disclosure under Regulation 30(5) of LODR 2015 - 10.12.2015 (PDF • 2016-01-12)